Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q48131172)
Watch
English
Eradication of spontaneous malignancy by local immunotherapy.
scientific article published in January 2018
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
title
Eradication of spontaneous malignancy by local immunotherapy
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
main subject
immunotherapy
1 reference
based on heuristic
inferred from title
author
Idit Sagiv-Barfi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
Aaron T Mayer
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
Sanjiv Sam Gambhir
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
Ronald Levy
series ordinal
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
Israt S Alam
series ordinal
4
object named as
Israt S Alam
1 reference
stated in
Europe PubMed Central
retrieved
13 March 2020
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
PMC publication ID
5997264
author name string
Debra K Czerwinski
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
Shoshana Levy
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
language of work or name
English
0 references
publication date
1 January 2018
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
published in
Science Translational Medicine
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
volume
10
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
issue
426
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
cites work
Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Fcgamma receptors as regulators of immune responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
OX40 costimulation turns off Foxp3+ Tregs.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Regulatory T cell lineage specification by the forkhead transcription factor foxp3
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Transgenic Polyoma middle-T mice model premalignant mammary disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
The loss of estrogen and progesterone receptor gene expression in human breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Role of HER2 gene overexpression in breast carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
30 June 2018
A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
14 August 2018
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
14 August 2018
Intratumoral anti-CTLA-4 therapy: enhancing efficacy while avoiding toxicity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
14 August 2018
Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
14 August 2018
Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
14 August 2018
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
14 August 2018
Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5997264
retrieved
14 August 2018
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/29386357
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/29386357
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/29386357
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
In vivo depletion of FoxP3+ Tregs using the DEREG mouse model
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/29386357
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1126/SCITRANSLMED.AAN4488
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
PMC publication ID
5997264
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
PubMed publication ID
29386357
1 reference
stated in
Europe PubMed Central
PMC publication ID
5997264
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29386357%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit